The largest association of independent nuclear pharmacies in the U.S. has filed a lawsuit accusing Jubilant DraxImage, a big supplier of radiology medicines, with a range of anticompetitive practices that have resulted in dramatically higher prices that have allegedly hurt patient care.

At issue are a series of actions that Jubilant has taken over the past few years and that also prompted the U.S. Federal Trade Commission to open an investigation last year. The moves included buying rival medicines that were then withheld from customers, boosting prices on two key drugs, and requiring pharmacies to purchase bundles of its products, the lawsuit stated.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy